Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders

Karamé A.a, b · Labeeuw M.a, b · Trolliet P.a · Caillette-Beaudoin A.c · Cahen R.a · Ecochard R.d, e · Galland R.c · Hallonet P.c · Pouteil-Noble C.a, b · Villar E.a

Author affiliations

aNephrology and Renal Transplantation, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, bUniversité de Lyon-1, Villeurbanne, cCentre Associatif Lyonnais de Dialyse, Lucien Hussel Hospital, Vienne, and dDepartment of Biostatistics, Hospices Civils de Lyon, and eUMR CNRS 5558, Université de Lyon-1, Lyon, France

Related Articles for ""

Nephron Clin Pract 2009;112:c268–c275

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

For eJournal Archive and eJournal Backfiles information please contact service@karger.com

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 11, 2008
Accepted: January 23, 2009
Published online: June 16, 2009
Issue release date: August 2009

Number of Print Pages: 1
Number of Figures: 2
Number of Tables: 3


eISSN: 1660-2110 (Online)

For additional information: https://www.karger.com/NEC

Abstract

Background/Aims: In diabetics with end-stage renal disease (ESRD), risk of death has been reported to be non-constant after the first dialysis, and different outcomes have been observed between genders. We assessed the impact of type 2 diabetes (T2DM) on mortality in dialysis regarding its differential effect by gender using time-dependent analyses. Methods: All T2DM and non-diabetic (no-DM) patients who started dialysis in two renal units in Lyon, France, between January 1, 1995, and December 31, 2007, were included. In multivariate analyses, the Cox model and Shoenfeld residual approach were used to assess the effect of T2DM on dialysis mortality by gender. Results: We included 235 T2DM (males: 57.9%) and 480 no-DM (males: 65.6%) patients. In males, the adjusted hazard ratio (aHR) for death in T2DM versus no-DM was 0.83 (p = 0.20) and was constant over time after the first renal replacement therapy (RRT) (p = 0.88). In females, aHR for death in T2DM versus no-DM patients was not constant over time (p = 0.002). It was 0.64 (p = 0.13) within the first year after the first RRT and 2.10 (p = 0.002) after the first year. Evolutions with time of these aHR by gender were significantly different (p = 0.009). Conclusions: T2DM was associated with death only in females. This association was not constant over time after the first dialysis.

© 2009 S. Karger AG, Basel


References

  1. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B: Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol 2003;18:793–800.
  2. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes Care 1998;21:1138–1145.
  3. Salles GF, Bloch KV, Cardoso CR: Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care 2004;27:1299–1305.
  4. van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD: Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000). Kidney Int 2005;67:1489–1499.
  5. Couchoud C, Stengel B, Jacquelinet C: REIN annual report 2005. Renal Epidemiology and Information Network and Agence de la Biomédecine. Nephrol Ther 2007;3(suppl 1):S1–S82.
    External Resources
  6. Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B: Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 2007;50:922–929.
  7. Villar E, Chang SH, McDonald SP: Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991–2005). Diabetes Care 2007;30:3070–3076.
  8. US Renal Data System: USDRS 2006 Annual Data Report – Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
  9. Jagger KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD: The epidemic of ageing in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 2003;60:352–360.
    External Resources
  10. Lutz W, Sanderson W, Scherbov S: The coming acceleration of global population ageing. Nature 2008;451:716–719.
  11. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053.
  12. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580–591.
  13. James WP, Rigby N, Leach R: Obesity and the metabolic syndrome: the stress on the society. Ann NY Acad Sci 2006;1083:1–10.
  14. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J: Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005;48:856–861.
  15. Juutilanen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laasko M: Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004;27:2898–2904.
  16. Villar E, Remontet L, Labeeuw M, Ecochard R: Effects of age, sex and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007;18:2125–2134.
  17. Trovato F, Heysen NB: A varied pattern of change of the sex differential in survival in the G7 countries. J Biosoc Sci 2006;38:391–401.
  18. Villar E, Rabilloud M, Berthoux P, Vialtel P, Labeeuw M, Pouteil-Noble C: A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes. Nephrol Dial Transplant 2004;19:207–214.
  19. Shoenfeld DA, Richter DJ: Nomograms for calculating the numbers of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163–170.
  20. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot F, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C: The renal epidemiology and information network (REIN): a new registry for end-stage renal disease. Nephrol Dial Transplant 2006;21:411–418.
  21. Villar E, Frimat L, Ecochard R, Labeeuw M: Specificities of the methodology of survival analysis in dialysis patients. Nephrol Ther 2008;4:553–561.
  22. Therneau TM, Grambsch PM: Testing proportional hazards; in Grambsch P, Mayo Foundation (eds): Modeling Survival Data: Extending the Cox Model. Rochester, Springer, 2000, pp 127–152.
  23. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515–526.
    External Resources
  24. Lee WL, Cheung AM, Cape D, Zinman B: Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000;23:962–968.
  25. McFadden E, Luben R, Wareham N, Bingham S, Khaw KT: Occupational social class, educational level, smoking and body mass index, and cause-specific mortality in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol 2008;23:449–458.
  26. de Mutsert R, Snidjer MB, van der Sman-de Beer F, Seidell JC, Boeschoten EW, Krediet RT, Dekker JM, Vandenbroucke JP, Dekker FW, for the Netherlands Cooperative Study on the Adequacy Dialysis-2 (NECOSAD) Study Group: Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007;18:967–974.
  27. Williams ME, Lacson EJ, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503–1510.
  28. de Mutsert RD, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, the NECOSAD Study Group: Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008;23:2957–2964.
  29. Stenkivel P, Barany P, Chung SH, Lindholm B, Heimbürger O: A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002;17:1266–1274.
  30. Teede HJ: Sex hormones and the cardiovascular system: effects on arterial function in women. Clin Exp Pharmacol Physiol 2007;34:672–676.
  31. Norris K, Nissesson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008;19:1261–1270.
  32. Cukor D, Peterson RA, Cohen SD, Kimmel PL: Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol 2006;2:678–687.
  33. Depmer T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macin E, Milford E, Owen W, Star R, Toto R, Eknoyan G: Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 2004;66:1386–1394.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 11, 2008
Accepted: January 23, 2009
Published online: June 16, 2009
Issue release date: August 2009

Number of Print Pages: 1
Number of Figures: 2
Number of Tables: 3


eISSN: 1660-2110 (Online)

For additional information: https://www.karger.com/NEC


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.